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Abstract 
 
The aim of this study was to assess the relationship between beliefs about the causes of illness, 
glycaemic control, and affective status of overweight and obese women and men with type 2 
diabetes. The clinical sample included 88 patients (46 males), aged from 31 to 79 years. Patients 
were examined in the Outpatient Clinic for Endocrinology, Diabetes and Metabolic Diseases in the 
Clinical Medical Centre Rijeka. Psychological measurements included the Revised Illness 
Perception Questionnaire and the Hospital Anxiety and Depression Scale. Patients' body weight, 
height and glycaemic control (HbA1c) were also obtained.The results show that body mass index 
(BMI) is not significantly correlated with the level of HbA1c, nor with measured psychological 
variables (psychological attributions of illness, anxiety and depressive symptoms). A stronger belief 
that illness was caused by psychological factors is correlated with more symptoms of anxiety and 
depression in patients. There was a significant main effect of patients' sex on psychological 
attributions and anxiety symptoms. Women reported stronger beliefs that psychological factors 
might have been the cause of their illness and showed higher levels of anxiety symptoms than men. 
There was no significant main effect of glycaemic control on measured psychological variables. The 
results suggest that in working with T2DM patients it is important to pay attention to psychological 
aspects of illness, taking into account the patient's sex. Inquiring about diabetes causation beliefs 
and emotional status may be a way of recognizing possible barriers towards providing care.  
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Introduction 
 
Obesity and type 2 diabetes are metabolic diseases that are becoming worldwide 
epidemics (Everard & Cani, 2013; Lau, Carvalho, Pina-Vaz, Barbosa, & Freitas, 
2015). Obesity is accompanied by numerous, potentially life-threatening, comorbid 
disorders, huge economic costs, and its prevalence is increasing in almost all 
continents and in almost all developed countries (López-Jiménez & Cortés-
Bergoderi, 2011). According to the World Health Organization (2015) more than 1.9 
billion adults are overweight, among whom more than 650 million are obese. In 
Europe over 40% of adults have excessive body weight, and about 20% are obese 
(Berghoefer et al., 2008). A similar situation can be found in Croatia, where more 
than 20.4% of the adult population is obese (Musić Milanović, 2010). Among the 
many health problems that arise as a result of obesity, diabetes is one of the most 
serious, so in the 21st century it is essential to understand the pathological processes 
underlying obesity and metabolic co-morbidities, especially type 2 diabetes.  
Diabetes, as one of the most frequent consequences of obesity, is a complex, 
chronic disease that presents a huge challenge for the healthcare system due to its 
increasing prevalence and devastating complications (Zimmet, Magliano, Herman, 
& Shaw, 2014). Type 2 diabetes mellitus (T2DM) is the most common form of 
diabetes, accounting for 90% of cases globally. Unhealthy dietary habits and 
sedentary behaviour that lead to obesity are the major drivers of this global pandemic 
(Zimmet, 2017). According to the overall reported data, in 2016 Croatia registered 
almost 300 000 patients diagnosed with diabetes (Croatian Institute of Public Health, 
2016). Of people with T2DM, 79% of men and 84% of women are overweight or 
obese (Musić Milanović, 2010).  
People with diabetes are at risk of developing a variety of complications that 
negatively affect their quality of life and cause substantial premature mortality. 
Furthermore, diabetes-related complications account for a major part of healthcare 
costs associated with diabetes (Zhang et al., 2010). While microvascular 
complications, including retinopathy, nephropathy and neuropathy, tend to develop 
after the onset of diabetes, the risk of macrovascular complications, such as coronary 
heart disease, stroke and peripheral vascular disease, might be present even before 
the diagnosis of diabetes, partly driven by underlying insulin resistance and 
coexisting cardiometabolic risk factors (van Dieren, Beulens, van der Schouw, 
Grobbee, & Neal, 2010). In addition to vascular complications, diabetes is also 
associated with other co-morbidities, including increased risk of different 
malignancies, reproductive disorders, osteoporosis and sleep apnoea (Dede, Tournis, 
Dontas, & Trovas, 2014; Giovannucci et al., 2010). Good glycaemic control is 
essential in preventing diabetic complications. The level of glycosylated 
haemoglobin (HbA1c) provides a measure of glycaemic control during 8-12 weeks 
prior to testing (Jeffcoate, 2004). Target HbA1c goal of < 7% may be recommended 
for patients with short disease duration, long life expectancy, and no significant 
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cardiovascular disease. However, less stringent HbA1c goals may be considered 
appropriate for patients with advanced complications, limited life expectancy, a 
history of severe hypoglycaemia and extensive comorbid conditions (American 
Diabetes Association, 2018). A systematic review and meta-analysis showed that 
psychosocial interventions modestly but significantly improved HbA1c and mental 
health outcomes (Harkness et al., 2010). A complex interaction between genetic 
predisposition, environmental and behaviour/psychological factors drives disease 
aetiologies – the same is true for obesity and diabetes. 
Diabetes is often accompanied by psychological factors, especially depression, 
anxiety and other mood disorders, since people with diabetes face the threat of 
blindness, amputation, end-stage kidney disease, hypoglycaemia and premature 
death (Piette, Richardson, & Valenstein, 2004). Compared with the general 
population, diabetic patients are twice as likely to experience anxiety and depression 
disorders (Anderson, Freedland, Clouse, & Lustman, 2001; Egede, Zheng, & 
Simpson, 2002). Collins, Corcoran, and Perry (2009) suggest that the prevalence of 
depressive symptoms in patients with diabetes is between 10.4 and 11.2%, while 
22.4% of them show mild to severe depression. An international study concerning 
patients with diabetes, which was carried out in 17 countries, showed that major 
depression was 40% more frequent in patients with diabetes compared to the control 
group (Lin et al., 2008). Depression is consistently associated with hyperglycaemia, 
it increases the likelihood and risk of diabetes-related complications and 
nonadherence with prescribed therapy (de Groot, Anderson, Freedland, Clouse, & 
Lustman, 2001; Gonzalez et al., 2008; Lustman et al., 2000). Research findings show 
that subclinical symptoms of depression are common and persistent in patients with 
diabetes, are more often associated with poor regulation of diabetes than with mood 
disorders per se, as well as with nonadherence to treatment, increasing the risk of 
complications and mortality (Gonzalez, Esbitt, Schneider, Osborne, & Kupperman, 
2011; Zhang et al., 2005). Diabetes and depression seem to be inter-related, even 
though depression frequently precedes the development of T2DM (Gonzalez et al., 
2011; Mezuk, Eaton, Albrecht, & Golden, 2008). One possible explanation of this 
relationship is that biological factors underlying depression act as mediators between 
depression and disease outcome, but on the other hand it is also reasonable to take 
into account negative health behaviours related to depression as possible mediators, 
such as inactivity, poor eating habits, smoking, and failure to comply with 
recommendations during treatment (Gonzalez et al., 2011). 
The prevalence of symptoms of mild to severe anxiety (32%) in patients with 
diabetes is considerably higher than in the general population (15%) (Collins et al., 
2009; Lloyd, Dyer, & Barnett, 2000). The likelihood of developing anxiety disorder 
is about 20% higher in patients with diabetes compared to non-diabetic individuals 
(Lin et al., 2008). It is quite difficult to determine to what extent some of the anxiety 
disorders or the subclinical level of anxiety occur in people with diabetes. In mixed 
sample studies with patents with T2DM and T1DM the presence of anxiety 
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symptoms ranges between 40-42% (Grigsby, Anderson, Freedland, Clouse, & 
Lustman, 2002; Mitsonis, Dimopoulous, & Psarra, 2009). Anxiety is often associated 
with the phobia and/or with a significant fear of self-injecting or self-testing in about 
9 to 28% of patients, which could become a major problem in treatment adherence 
(Mollema, Snoek, Heine, & van der Ploeg, 2001). Among patients who take insulin, 
the fear of hypoglycaemia or low blood sugar levels may be present (Gonzalez et al., 
2011; Weinger & Lee, 2006). Hypoglycaemia often causes irritability, cognitive 
dysfunction, tremors and excessive sweating. If glucose drops to a critically low 
level, a loss of consciousness occurs, and in some cases even death. To avoid the 
risks related to low blood glucose levels, patients prefer to keep higher blood sugar 
levels (Weinger & Lee, 2006). Other research shows that anxiety is associated with 
problems of facing diabetes, poor clinical outcomes, and finally it decreases a 
person's functionality and quality of life, even at the sub-clinical level (Gonzalez et 
al., 2011).  
Depressive and anxious individuals with diabetes are less willing to follow self-
care and dietary recommendations, are less physically active, and are less likely to 
take prescribed medications (Ciechanowski, Kanton, & Russo, 2000; Collins et al., 
2009). Therefore, the reduction of depressive and anxious symptoms in diabetic 
patients could be very useful in controlling glycaemia (Collins et al., 2009). Patients 
are likely to show psychological vulnerability after the diagnosis of diabetes, when 
their medical condition changes, when the need for intensified treatment is apparent 
(e.g., insulin initiation), especially after the onset of diabetes-related complications. 
Research findings suggest that patients' behaviours are focused on self-care, 
including maintaining glycaemic control in T2DM, as a result of beliefs about or 
perception of the disease (Harvey & Lawson, 2009). 
A person's belief that diabetes is a disease that can be controlled will trigger 
other forms of behaviour compared to beliefs that the disease is somewhat out of 
their control. Intense emotional reactions that accompany the disease are also a 
consequence of beliefs about the illness (Mc Sharry, Moss-Morris, & Kendrick, 
2012). The Common-Sense Model (CSM) of illness, as postulated by Leventhal and 
colleagues (Leventhal, Meyer, & Nerenz, 1980; Leventhal, Nerenz, & Steele, 1984), 
provides a theoretical perspective of the process used by persons to make sense of a 
disease threat, and for understanding the factors affecting the perception of disease 
as well as its influence on future behaviour, health outcomes and regulatory 
behaviours. Illness representations reflect a person's implicit 'common sense' beliefs 
of an illness derived from both lay and expert sources as well as personal and 
vicarious experiences with a particular disease (Henderson, Orbell, & Hagger, 2009), 
activated in response to somatic and functional changes (Leventhal, Philips, & Burns, 
2016). Leventhal et al. (1984) proposed that an illness or symptoms can generate 
both cognitive and emotional representations. Perceptual domains include cognitive 
representations of illness in five core domains: identity, consequences, cause, 
timeline and control/cure, while the emotional aspects include negative reactions 
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such as fear, anger and distress, anxiety or depression (Broadbent, Petrie, Main, & 
Weinman, 2006; Leventhal et al., 1980, 1984, 2016).  
Psychological attributions refer to the possible causes or impacts associated 
with the development of diabetes. There are internal and external factors that interact and 
may trigger the disease. The interaction of factors, such as eating habits, lack of rest, 
exposure to life stressors or bacteria/viruses, increase the sensitivity of a person to 
disease (Santos, Hurtado-Ortiz, Lewis, & Ramirez-Garcia, 2015). Although some of 
the causes of disease are external, like viruses or stress, they are simultaneously 
experienced as an internal state, depending on how the person experiences and 
interprets them (Lau, Bernard, & Hartman, 1989). Understanding the possible causes 
of a disease is, according to the CMS model, one of the basic components that 
characterise the representation of illness (Leventhal et al., 2016).  
In this paper we will focus on psychological factors and metabolic outcomes in 
overweight and obese women and men with type 2 diabetes. Specifically, the aim of 
this study is to assess the relationship between beliefs about the causes of disease, 
glycaemic control, and affective status (anxiety and depression) of overweight and 
obese persons with type 2 diabetes. In line with the review of research findings 
related to type 2 diabetes and obesity, we expect that the level of anxiety and 
depression in women with diabetes will depend more on successfulness of glycaemic 
control and body weight than in men with diabetes. Furthermore, we expect that 
women with diabetes will attribute disease causes to psychological factors 
significantly more than men with diabetes. 
 
 
Method 
 
Participants 
 
The sample consisted of 88 patients (46 males) with type 2 diabetes (T2DM) 
who were treated in the Outpatient Clinic for Endocrinology, Diabetes and Metabolic 
Diseases in the Clinical Medical Centre Rijeka. Patients' body mass index (BMI) 
ranged from 22.77 to 50.30 kg/m2 (M = 31.38; SD = 5.57). Among them, 6.8% had 
normal weight, 44.3% were overweight, and 48.9% were obese. In accordance with 
the aim of this study, only overweight and obese patients (N = 82) were included in 
further data analyses. In this subsample, the patients' age ranged from 31 to 79 years 
(M = 60.12; SD = 9.81). The average duration of T2DM was 10.67 years (51.9% of 
subjects have had T2DM for up to 10 years, 18.5% of subjects have had T2DM for 
up to 15 years, while 11.1% of subjects have been suffering from T2DM for more 
than 20 years). Regarding successfulness in glycaemic control, 53.7% patients had 
poor (HbA1c > 7.5%), and 46.3% patients had good glycaemic control (HbA1c < 
7.5%). 
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Measures 
 
Glycaemic Control (HbA1c) 
 
The level of glycosylated haemoglobin (HbA1c) was used as an indicator of the 
patients' glycaemic control. The HbA1c test measures the percentage of glucose in 
the blood joined with the haemoglobin molecule. The values of glycosylated 
haemoglobin below 7.5% indicate good regulation of glycaemia, while values above 
7.5% indicate poor regulation (Berg, 2013).  
 
Body Mass Index (BMI) 
 
Body mass index was used as an indicator of (un)healthy body weight. BMI 
was calculated by dividing the patient's body weight (in kilograms) by the square of 
his/her body height (in meters). 
 
Self-Assessment Questionnaires 
 
The patient's perceptions of the causes of illness were evaluated using a subscale 
"Causes" from the Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris 
et al., 2002), an instrument that evaluates different components of the representation 
of illness based on Leventhal's Self-Regulatory Model. The subscale "Causes" 
consists of a list of 18 possible causes of illness. The participants had to indicate what 
they considered to be the cause(s) of their illness. All items were rated on a 5-point 
Likert-type scale (from 1 = strongly disagree to 5 = strongly agree). Following a 
factor analysis, the authors of the questionnaire suggested that the causes might be 
divided into four factors: Psychological attributions (6 items; e.g., "Family problems 
or worries" and "My emotional state"), Risk factors (7 items; e.g., "Alcohol" and 
"Hereditary"), Immune system factors (3 items; e.g., "A germ or virus" and "Altered 
immunity") and Accident or chance factors (2 items; "Chance or bad luck" and 
"Accident or injury") (Moss-Morris et al., 2002). Higher scores on each subscale 
represent stronger beliefs in a particular type of illness causes. In the present study, 
Cronbach's alpha coefficients for Psychological attributions, Risk factors, Immune 
system factors and Accident or chance factors were .73, .41, .44, and .62, 
respectively. In subsequent data analysis, only the score obtained from the subscale 
Psychological attributions was used, due to the fact that the reliability coefficient for 
that subscale was the only satisfactory one. 
Symptoms of anxiety and depression were measured by the Hospital Anxiety 
and Depression Scale (HADS; Zigmond & Snaith, 1983). The HADS is a 14-item 
self-report screening scale. It has two subscales, each consisting of 7 items aimed to 
assess either symptoms relevant to anxiety (HADS-A) or symptoms relevant to 
depression (HADS-D) over the period of the past 2 weeks. Participants have rated 
the items on a 4-point scale (0 through 3). A total score for each subscale is obtained 
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by summing the 7 items, with a possible range from 0 to 21. Higher scores represent 
more symptoms related to anxiety and depression. Generally, a score of 7 or less is 
considered to be within the normal range, between 8 and 10 is considered as "a 
possible case", and a score of 11 or more is considered as "a probable case" of anxiety 
or depression. In this sample, the Cronbach's alpha coefficients for the HADS-A and 
HADS-D were .84 and .71, respectively. 
Questionnaires were translated into Croatian language (two forward and one 
back translation with adjustment for Croatian population).  
 
Procedure 
 
The data were collected during the patients' visit to the Outpatient Clinic for a 
medical check-up. The psychologists had them complete the self-assessment 
questionnaires, and the medical team obtained the height and weight of each 
participant, as well as the level of glycosylated haemoglobin (HbA1c). The hospital's 
ethics committee approved the study and a written informed consent was obtained 
from each participant included in the study.  
 
 
Results 
 
Statistical analyses were conducted using IBM SPSS Statistics for Windows, 
Version 20.0 (IBM Corp., 2011). 
Means, standard deviations and ranges for psychological measures are 
presented in Table 1.  
 
Table 1 
Means, Standard Deviations and Ranges for all Psychological Measures 
Scale name N of items M SD Range 
IPQ-R     
Psychological attributions 6 17.18 4.02 9-26 
HADS     
Anxiety 7 5.44 3.57 0-14 
Depression 7 4.84 3.30 0-13 
Note. IPQ-R - Revised Illness Perception Questionnaire; HADS - Hospital Anxiety and Depression Scale 
 
Regarding the level of anxiety, 76.3% of patients were not anxious, 11.2% 
showed signs of possible anxiety, and 12.5% of patients had symptoms suggesting 
probable anxiety. In terms of depressive symptoms, 73.8% of the patients were not 
depressed, 20.0% had symptoms suggesting possible depression, and 6.2% of the 
patients had symptoms suggesting probable depression. 
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To examine the relationship among BMI, HbA1c, psychological attributions, 
anxiety and depressive symptoms, a correlation analysis was conducted. Pearson 
correlation coefficients between all variables are presented in Table 2.  
 
Table 2 
Correlations between Measured Variables 
Variables HbA1c 
Psychological 
attributions 
Anxiety Depression 
BMI .11 .09 .08 .21 
HbA1c - .07 .24* .15 
Psychological attributions  - .58** .44** 
Anxiety   - .63** 
*p < .05; **p < .01. 
 
As can be seen in Table 2, no significant correlation between body mass index 
of patients suffering from T2DM and their level of HbA1c (a measure of glycaemic 
control) was found. In addition, BMI was not significantly correlated with 
psychological attributions of illness, anxiety and depressive symptoms. The level of 
HbA1c was significantly correlated only with anxiety symptoms, but that correlation 
was weak. Correlation analyses showed that a stronger belief that illness was caused 
by psychological factors was correlated with more symptoms of anxiety and 
depression in patients.  
Because there were no significant differences (p > .05) between overweight and 
obese patients in the level of HbA1c and psychological variables, they were treated 
as a single group in further analyses.  
To examine the effects of glycaemic control (measured by the level of HbA1c) 
and patient's sex on causal attributions for diabetes, as well as on anxiety and 
depressive symptoms, separate two-way between-subjects ANOVAs were run for 
each of the dependent measures. In all of these analyses a 2 (glycaemic control: good 
versus poor) x 2 (sex: male versus female) between-subjects ANOVA design was 
used. 
In the first ANOVA, psychological attributions were set as the dependent 
variable. Results revealed that there was a significant main effect of patient's sex on 
psychological attributions (F(1,78) = 4.161, p < .05). Women reported stronger beliefs 
that psychological factors might have been the cause of their illness than men (Mwomen 
= 18.15, Mmen = 16.30). The Partial eta2 value of 0.051 indicates that 5.1% of the 
between subjects variance is accounted for by the patient's sex. There was no 
significant main effect of glycaemic control on psychological attributions, as well as 
no significant interaction between glycaemic control and sex. The effects of 
glycaemic control and patients' sex on psychological attributions are shown in Figure 
1. 
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Figure 1. Differences in psychological attributions between female and male patients with 
poor and good glycaemic control. 
 
In the second ANOVA, in which the level of anxiety symptoms was set as the 
dependent variable, the main effect of patients' sex was again significant (F(1,76) = 
7.523, p < .01). Women reported higher levels of anxiety symptoms than men did 
(Mwomen = 6.60, Mmen = 4.38). The Partial eta2 value of 0.090 indicates that 9% of the 
between subjects variance is accounted for by the patient's sex. The main effect of 
glycaemic control was not significant, as well as the interaction between glycaemic 
control and sex. The effects of glycaemic control and patient's sex on the level of 
anxiety symptoms are shown in Figure 2. 
 
 
Figure 2. Differences in anxiety symptoms between female and male patients with poor and 
good glycaemic control. 
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In the third ANOVA, in which the level of depressive symptoms was set as the 
dependent variable, there were no significant main effects of glycaemic control and 
sex, as well as no significant interaction between glycaemic control and sex, which, 
however, approached significance (F(1,76) = 3.319, p = .072). The Partial eta2 value of 
0.042 indicates that 4.2% of the between subjects variance is accounted for by 
glycaemic control x sex interaction. 
 
 
 
Figure 3. Differences in depressive symptoms between female and male patients with poor 
and good glycaemic control. 
 
 
Discussion 
 
The aim of this study was to explore the relationship between beliefs about the 
causes of disease, glycaemic control and affective status in overweight and obese 
persons with type 2 diabetes. The results show that anxiety is associated with poorer 
disease control and psychological attributions related to the cause of the illness. We 
assume that the presence of anxiety in patients with T2DM could lead to difficulties 
in dealing with diabetes, worse clinical outcomes, reduced functionality and 
diminished overall quality of life (Gonzalez et al., 2011). The main findings of this 
study are in line with other research results confirming that the reduction of anxiety 
symptoms could be very useful in glycaemia regulation (Collins et al., 2009). In our 
sample, almost one quarter of patients show possible or probable anxiety, which is 
greater than in the general population but somewhat lower than found in other studies 
(Collins et al., 2009; Lloyd et al., 2000). Interestingly, in the context of the 
association of anxiety symptoms with psychological attributions, more anxiety 
symptoms are present in those patients who attribute the cause of their illness to 
negative thoughts about the illness, family problems or problems caused by the 
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disease, their emotional state, personality, and perception of the stressfulness of 
certain situations. The lack of a person's capacity to use coping strategies directed to 
problem solving generates fear, loneliness, and increases anxiety. Furthermore, 
negative thoughts that cause unpleasant emotions boost the anxiety even more. The 
more anxious a person is his/her coping with the disease worsens and he/she enters 
into a vicious cycle of anxiety maintenance, which makes it difficult to regulate 
glycaemia. The results of this study have also shown that the use of psychological 
attributions in understanding diabetes was associated with a more frequent 
experience of depressive symptoms. Depression is primarily associated with 
psychological attributions related to beliefs that bad and negative things will happen 
in a person's life or that the disease is caused by family problems and concerns, as 
well as mood states such as feeling down, lonely and anxious. This negative mental 
attitude is associated with a sense of helplessness, which is consistently related to 
increased risk of complications in diabetes and nonadherence to prescribed therapy, 
as frequently shown in various studies (de Groot et al., 2001; Gonzalez et al., 2008; 
Lustman et al., 2000). In our sample, 20% of patients reported possible symptoms 
and 6% probable symptoms of depression, which is significantly more than in other 
studies (Collins et al., 2009). Van Dooren et al. (2016) believe that a person's own 
awareness of diabetes can contribute to higher levels of depressive symptoms, and 
therefore one must deal with chronic illness or its complications. Type 2 diabetes 
self-management represents a burden for the patients; it requires discipline and 
perseverance in everyday activities, such as maintaining a particular diet, regular 
exercise, enough rest, taking prescribed medication and monitoring glucose levels. 
Insulin therapy is particularly demanding and is associated with elevated 
psychological distress (Delahanty et al., 2007). Additionally, complications caused 
by diabetes may also cause functional impairments such as reduced mobility, visual 
impairment, fatigue, and pain, further disturbing/reducing patients' quality of life 
(van Dooren et al., 2016).  
In explaining psychological distress, particularly depression in diabetic patients, 
it is important to emphasize the possible biological mechanisms as well. 
Cerebrovascular disease may be a causal or vulnerability factor in the onset of 
depression in diabetic persons. The hypothesis of "vascular depression" refers to the 
possibility that brain damage, especially frontal lobe damage caused by small vessel 
disease, could be related to the presence of depressive symptoms (Alexopoulos et al., 
1997; Krishnan, Hays, & Blazer, 1997). Also, a higher level of arterial stiffening, 
which is an early phenomenon in the development of cardiovascular disease, rapidly 
develops in T2DM, but more often in depressed individuals. Another hypothesis 
emphasizes the importance of the systemic low-grade inflammation as a key factor 
in the development of cardiovascular disorders, which is very common in T2DM, 
but also plays a significant role in the aetiology of depression and obesity (Taylor, 
Aizenstein, & Alexopoulos, 2013). Bot et al. (2013) assume that the blood glucose 
level itself may be a compelling regulator for mood states as well. Prolonged 
hyperglycaemia or hypoglycaemia are able to induce negative emotional states in 
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T2DM. Furthermore, recent findings stress the important role of brain-gut 
communication, or more precisely the brain-gut-islet connection, in pathogenesis of 
obesity and type 2 diabetes (Woods, Benoit, & Clegg, 2006). A new perspective for 
developing efficient and precise therapeutics for metabolic diseases has arisen from 
this fact (Clemmensen et al., 2017). It includes not only pharmacotherapeutics, but 
also psychological and cognitive interventions aimed at intervening between the 
affective-cognitive system of the brain and the gut/islet miscommunication. 
 
Sex Differences in Psychological Attribution, Anxiety, Depression and 
Glycaemic Control 
 
As expected, women in this study in a larger degree believe that psychological 
factors have led to the development of their diabetes than men, regardless of whether 
their glycaemic control is good or bad. Women choose more often psychological 
causes (e.g., stress/worry, emotional state, family problems) as the main contributors 
to the development of their T2DM. Concha, Mayer, Mezuk, and Avula (2016) found 
that, accompanied by hereditary causes and an unhealthy lifestyle, the concept of 
stress or negative emotions emerged as a significant direct and indirect link to the 
onset of diabetes in the Hispanic/Latino patients. The authors used a qualitative 
research design and have conducted interviews with patients in order to understand 
the cause of T2DM. Content analyses revealed the role of emotional distress in 
disengagement or as an obstacle to self-care activities in diabetes. Although we have 
not conducted interviews with our patients, the results of this study support the idea 
that discussing about the psychological causes of their illness may be a useful 
technique for women with diabetes and help them achieve greater adherence to 
treatment, increasing the likelihood of maintaining self-care activity and 
consequently achieving better regulation of glycaemia, and better quality of life.  
Women are also significantly more anxious than men, regardless of glycaemic 
control. The explanation can be found in the fact that we have included in the study 
exclusively overweight and obese patients. A sedentary lifestyle that leads to obesity 
has negative effects on psychological well-being. Obese and overweight people often 
avoid physical activity, partly because it is harder for them to do exercise, and partly 
because of the shame associated with their body. Dunn, Trivedi, Kampert, Clark, and 
Chambliss (2005) found that physical activity alleviates anxiety through shifting 
attention from negative thoughts and worries, increasing the possibilities of social 
contacts, and changing the biochemistry of the brain and, consequently, favourably 
affecting mood. This finding helps to understand the relationship between anxiety 
and sedentary lifestyle, which leads to obesity. The relationship can also be observed 
inversely, since psychological disturbances can also lead to weight gain. For 
example, research has shown that anxious people exaggerate intake of food, 
especially socially anxious individuals, which in some of them may result in obesity 
(Dunn et al., 2005). We can suppose that the negative consequences of being 
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overweight are greater for women because body dissatisfaction and overweightness 
can increase anxiety, especially in women who constantly worry about their own 
health. 
Interestingly, there were no significant differences in depressive symptoms 
between patients with good and bad glycaemic control. However, it is important to 
stress the unexpected finding of this study related to the marginally significant 
interaction effect of sex and glycaemic control (p < .073; Partial eta2 = 0.042). It 
means that men with good glycaemic control express more depressive symptoms 
compared to women with good glycaemic control and men with bad glycaemic 
control. Of course, the clinical relevance of this result should be interpreted with 
caution. However, this result emphasises the need for a different and individualised 
approach to male and female patients with T2DM. Men with good glycaemic control 
are at a greater risk of developing depressive symptoms (probably due to emotional 
engagement in disease control that can trigger the feeling of helplessness and 
unhappiness, as stated in the following item: Because of illness I cannot enjoy the 
things I have previously enjoyed or have to give up on a common lifestyle or I can 
no longer enjoy my favourite food). Therefore, more attention should be paid to 
accompanying negative mood in men with good glycaemic control and women in 
general, regardless of the successfulness of their glycaemic control. 
 
Limitations and Contribution of this Study 
 
Of course, the results of this preliminary study should be interpreted with 
caution. A relatively small sample size is the most significant limitation of the study, 
making generalizations difficult and affecting external validity. No causal 
conclusions can be made, as the study is correlational in nature. But there are some 
advantages of the study. First, our sample consists of an equal number of men and 
women, allowing us to explore gender differences in psychological and biological 
variables. Second, our sample consists of overweight and obese patients with 
diabetes, which is the most common co-morbidity, nowadays gaining epidemic 
proportions. And third, although a great number of studies from different countries 
investigate the Leventhal CSM model with patients with various diseases, similar 
studies in Croatia are very rare, especially with obese patients with diabetes. This 
study links obesity and type 2 diabetes and explores some of the variables related to 
both conditions because the precise mechanisms linking the two conditions still 
remain unclear.  
The presented results provide support to an individualised approach to 
overweight and obese women and men with diabetes, which could improve patients' 
care and enhance health outcomes. One of the most important aspects of 
communication with this group of patients is to understand patients' beliefs about the 
causes of their disease as well as accompanying emotional states. This would be of 
significant value in understanding patients' strengths and obstacles for using self-
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management strategies in glycaemic and weight control. To summarise, this 
preliminary study contributes to the understanding of possible effective interventions 
including an approach more tailored to women and men with both conditions. 
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Peso corporal y funcionamiento psicológico en los pacientes  
con diabetes mellitus tipo 2: Estudio preliminar 
 
Resumen 
 
El objetivo de este estudio fue evaluar la relación entre las convicciones sobre las causas de 
enfermedad, control glucémico y estado afectivo de mujeres y hombres con sobrepeso y obesos que 
sufren de diabetes tipo 2. La muestra clínica incluyó 88 pacientes (46 hombres), a la edad de entre 
31 y 79 años. Los pacientes fueron examinados en la Clínica de consulta externa de endocrinología, 
diabetes y enfermedades metabólicas del Centro hospitalario clínico de Rijeka. Mediciones 
psicológicas incluían el Cuestionario Revisado de Percepción de Enfermedad y la Escala de 
Ansiedad y Depresión Hospitalarias. También se obtuvieron el peso corporal, altura y control 
glucémico de los pacientes. Los resultados demuestran que el índice de masa corporal (IMC) no fue 
significativamente correlacionado con el nivel de HbA1c, ni con las variables psicológicas 
mesuradas (atribuciones psicológicas de la enfermedad, ansiedad y síntomas de depresión). 
Convicción más fuerte que la enfermedad fue causada por los factores psicológicos fue 
correlacionada con más síntomas de ansiedad y depresión en los pacientes. Hubo un efecto principal 
significativo del género de paciente en las atribuciones psicológicas y síntomas de ansiedad. Las 
mujeres mostraron convicciones más fuertes que los factores psicológicos podrían causar su 
enfermedad y mostraron también niveles más altos de síntomas de ansiedad que los hombres. No 
hubo un efecto principal más significativo del control glucémico en las variables psicológicas. Los 
resultados sugieren que trabajando con los pacientes con la DMT2 es importante prestar atención a 
los aspectos psicológicos de enfermedad, teniendo en cuenta el género de paciente. Examinar las 
convicciones sobre las causas de diabetes y el estado emocional podría posibilitarnos reconocer 
posibles obstáculos en proporcionar cuidados. 
 
Palabras clave: obesidad, diabetes, control glucémico, convicciones sobre las causas de 
enfermedad, ansiedad, depresión 
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